Literature DB >> 29095674

Bone Marrow Metastases: T2-weighted Dixon Spin-Echo Fat Images Can Replace T1-weighted Spin-Echo Images.

Yaël Maeder1, Vincent Dunet1, Raphael Richard1, Fabio Becce1, Patrick Omoumi1.   

Abstract

Purpose To test the potential of Dixon T2-weighted fat-only sequences to replace T1-weighted sequences for the detection of bone metastases, with the hypothesis that diagnostic performance with an alternative magnetic resonance (MR) imaging protocol (sagittal spin-echo Dixon T2-weighted fat-only and water-only imaging) would not be inferior to that with the standard protocol (sagittal spin-echo T1-weighted and spin-echo Dixon T2-weighted water-only imaging). Materials and Methods A total of 121 consecutive whole-spine MR imaging examinations (63 men; mean age ± standard deviation, 61.4 years ± 11.8) performed for suspected vertebral bone metastases were included in this retrospective, institutional review board-approved study. Quantitative image analysis was performed for 30 randomly selected spine levels. Qualitative analysis was performed separately by two musculoskeletal radiologists, who registered the number of metastases for each spine level. Areas under the curve with the protocols were compared on the basis of nonparametric receiver operating characteristic curve estimations by using a noninferiority test on paired data, with a best valuable comparator as a reference. Interobserver and interprotocol agreement was assessed by using κ statistics. Results Contrast-to-noise ratio was significantly higher on the alternative protocol images than on the standard protocol images (181.1 [95% confidence interval: 140.4, 221.7] vs 84.7 [95% confidence interval: 66.3, 103.1] respectively; P < .001). Diagnostic performance was not significantly inferior with the alternative protocol than with the standard protocol for both readers in a per-patient analysis (sensitivity, 97.9%-98.9% vs 93.6%-97.9%; specificity, 85.2%-92.6% vs 92.6%-96.3%; area under the curve, 0.92-0.96 vs 0.95, respectively; all P ≤ .02) and a per-spine level analysis (all P < .01). Interobserver and interprotocol agreement was good to very good (κ = 0.70-0.81). Conclusion Dixon T2-weighted fat-only and water-only imaging provide, in one sequence, diagnostic performance similar to that of the standard combination of morphologic sequences for the detection of probable spinal bone metastases, thereby providing an opportunity to reduce imaging time by eliminating the need to perform T1 sequences. © RSNA, 2017 An earlier incorrect version of this article appeared online. This article was corrected on November 6, 2017.

Entities:  

Mesh:

Year:  2017        PMID: 29095674     DOI: 10.1148/radiol.2017170325

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  Fat quantification of multifidus muscle using T2-weighted Dixon: which measurement methods are best suited for revealing the relationship between fat infiltration and herniated nucleus pulposus.

Authors:  Seul Ki Lee; Joon-Yong Jung; Yeo Ryang Kang; Jin-Hee Jung; Jae Jun Yang
Journal:  Skeletal Radiol       Date:  2019-07-24       Impact factor: 2.199

Review 2.  The Dixon technique for MRI of the bone marrow.

Authors:  Niels van Vucht; Rodney Santiago; Bianca Lottmann; Ian Pressney; Dorothee Harder; Adnan Sheikh; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2019-07-15       Impact factor: 2.199

3.  Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.

Authors:  Ahmed Larbi; Patrick Omoumi; Vassiliki Pasoglou; Nicolas Michoux; Perrine Triqueneaux; Bertrand Tombal; Catherine Cyteval; Frédéric E Lecouvet
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

4.  Advanced MR imaging of bone marrow: quantification of signal alterations on T1-weighted Dixon and T2-weighted Dixon sequences in red marrow, yellow marrow, and pathologic marrow lesions.

Authors:  Chayanit Sasiponganan; Kevin Yan; Parham Pezeshk; Yin Xi; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2019-10-12       Impact factor: 2.199

5.  Differentiation of bone metastases from benign red marrow depositions of the spine: the role of fat-suppressed T2-weighted imaging compared to fat fraction map.

Authors:  Sekyoung Park; Jin Do Huh
Journal:  Eur Radiol       Date:  2022-07-07       Impact factor: 7.034

6.  Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases.

Authors:  Erik Rud; Daniyal Noor; Kristina Flor Galtung; Fredrik Ottosson; Maciej Jacewicz; Eduard Baco; Peter Mæhre Lauritzen
Journal:  Eur Radiol       Date:  2022-08-08       Impact factor: 7.034

7.  Detection of vertebral metastases: a comparison between the modified Dixon turbo spin echo T2 weighted MRI and conventional T1 weighted MRI: a preliminary study in a tertiary centre.

Authors:  Seok Hahn; Young Han Lee; Jin-Suck Suh
Journal:  Br J Radiol       Date:  2018-03-15       Impact factor: 3.039

8.  Fracture of ankle: MRI using opposed-phase imaging obtained from turbo spin echo modified Dixon image shows improved sensitivity.

Authors:  Jin Hee You; In Hwan Kim; Jinwoo Hwang; Hye Sun Lee; Eun Hae Park
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

9.  Comparison of lumbar degenerative disc disease using conventional fast spin echo T2W MRI and T2 fast spin echo dixon sequences.

Authors:  Asif Saifuddin; Ramanan Rajakulasingam; Rodney Santiago; Mateen Siddiqui; Michael Khoo; Ian Pressney
Journal:  Br J Radiol       Date:  2021-03-08       Impact factor: 3.039

10.  Implementation of a sagittal T2-weighted DIXON turbo spin-echo sequence may shorten MRI acquisitions in the emergency setting of suspected spinal bleeding.

Authors:  Nico Sollmann; Charlotte Rüther; Simon Schön; Claus Zimmer; Thomas Baum; Jan S Kirschke
Journal:  Eur Radiol Exp       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.